imatinib has been researched along with Neoplasms in 10 studies
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some of them showed anti-cancer activities along with a number of reference compounds tested." | 1.37 | Synthesis and pharmacological evaluations of novel 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as a new class of anti-cancer agents. ( Dubey, PK; Pal, M; Piedrafita, FJ; Rajitha, C; Sunku, V; Veeramaneni, VR, 2011) |
| "Genetically defined cancer subsets, irrespective of tissue type, predict response to kinase inhibitors, and provide an important preclinical model to guide early clinical applications of novel targeted inhibitors." | 1.34 | Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling. ( Archibald, H; Dowell, L; Drew, L; Erlander, MG; Gray, NS; Greninger, P; Haber, DA; Hanke, JH; Iafrate, AJ; Lamb, J; Lee, D; Ma, XJ; Maheswaran, S; McDermott, U; Montagut, C; Njauw, CN; Raudales, R; Rothenberg, SM; Settleman, J; Sharma, SV; Sordella, R; Supko, JG; Tam, A; Tsao, H; Ulkus, LE, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, TA | 1 |
| Wodicka, LM | 1 |
| Shah, NP | 1 |
| Velasco, AM | 1 |
| Fabian, MA | 1 |
| Treiber, DK | 1 |
| Milanov, ZV | 1 |
| Atteridge, CE | 1 |
| Biggs, WH | 1 |
| Edeen, PT | 1 |
| Floyd, M | 1 |
| Ford, JM | 1 |
| Grotzfeld, RM | 1 |
| Herrgard, S | 1 |
| Insko, DE | 1 |
| Mehta, SA | 1 |
| Patel, HK | 1 |
| Pao, W | 1 |
| Sawyers, CL | 1 |
| Varmus, H | 1 |
| Zarrinkar, PP | 1 |
| Lockhart, DJ | 1 |
| McDermott, U | 1 |
| Sharma, SV | 1 |
| Dowell, L | 1 |
| Greninger, P | 1 |
| Montagut, C | 1 |
| Lamb, J | 1 |
| Archibald, H | 1 |
| Raudales, R | 1 |
| Tam, A | 1 |
| Lee, D | 1 |
| Rothenberg, SM | 1 |
| Supko, JG | 1 |
| Sordella, R | 1 |
| Ulkus, LE | 1 |
| Iafrate, AJ | 1 |
| Maheswaran, S | 1 |
| Njauw, CN | 1 |
| Tsao, H | 1 |
| Drew, L | 1 |
| Hanke, JH | 1 |
| Ma, XJ | 1 |
| Erlander, MG | 1 |
| Gray, NS | 2 |
| Haber, DA | 1 |
| Settleman, J | 1 |
| Bikker, JA | 1 |
| Brooijmans, N | 1 |
| Wissner, A | 1 |
| Mansour, TS | 1 |
| Rajitha, C | 1 |
| Dubey, PK | 1 |
| Sunku, V | 1 |
| Piedrafita, FJ | 1 |
| Veeramaneni, VR | 1 |
| Pal, M | 1 |
| Corradi, V | 1 |
| Mancini, M | 1 |
| Santucci, MA | 1 |
| Carlomagno, T | 1 |
| Sanfelice, D | 1 |
| Mori, M | 1 |
| Vignaroli, G | 1 |
| Falchi, F | 1 |
| Manetti, F | 1 |
| Radi, M | 1 |
| Botta, M | 1 |
| Kim, HG | 1 |
| Tan, L | 1 |
| Weisberg, EL | 1 |
| Liu, F | 1 |
| Canning, P | 1 |
| Choi, HG | 1 |
| Ezell, SA | 1 |
| Wu, H | 1 |
| Zhao, Z | 1 |
| Wang, J | 1 |
| Mandinova, A | 1 |
| Griffin, JD | 1 |
| Bullock, AN | 1 |
| Liu, Q | 1 |
| Lee, SW | 1 |
| Huang, TL | 1 |
| Mayence, A | 1 |
| Vanden Eynde, JJ | 1 |
| Li, Y | 1 |
| Lu, X | 1 |
| Ren, X | 1 |
| Ding, K | 1 |
| Gao, C | 1 |
| Li, B | 1 |
| Zhang, B | 1 |
| Sun, Q | 1 |
| Li, L | 1 |
| Li, X | 1 |
| Chen, C | 1 |
| Tan, C | 1 |
| Liu, H | 1 |
| Jiang, Y | 1 |
| Joshi, H | 1 |
| Patil, V | 1 |
| Tilekar, K | 1 |
| Upadhyay, N | 1 |
| Gota, V | 1 |
| Ramaa, CS | 1 |
2 reviews available for imatinib and Neoplasms
| Article | Year |
|---|---|
Some non-conventional biomolecular targets for diamidines. A short survey.
Topics: Amidines; Animals; Diabetes Mellitus, Type 2; DNA; Enzymes; Humans; Hypertension; Ion Channels; Myot | 2014 |
Some non-conventional biomolecular targets for diamidines. A short survey.
Topics: Amidines; Animals; Diabetes Mellitus, Type 2; DNA; Enzymes; Humans; Hypertension; Ion Channels; Myot | 2014 |
Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
Topics: Amino Acid Sequence; Animals; Discoidin Domain Receptors; Drug Discovery; Humans; Inflammation; Liga | 2015 |
Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
Topics: Amino Acid Sequence; Animals; Discoidin Domain Receptors; Drug Discovery; Humans; Inflammation; Liga | 2015 |
8 other studies available for imatinib and Neoplasms
| Article | Year |
|---|---|
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases.
Topics: Aminoquinolines; Aniline Compounds; Cell Line; Drug Resistance, Neoplasm; ErbB Receptors; Humans; In | 2005 |
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases.
Topics: Aminoquinolines; Aniline Compounds; Cell Line; Drug Resistance, Neoplasm; ErbB Receptors; Humans; In | 2005 |
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor | 2007 |
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor | 2007 |
Kinase domain mutations in cancer: implications for small molecule drug design strategies.
Topics: Amino Acid Sequence; Antineoplastic Agents; Drug Design; Enzyme Inhibitors; Humans; Molecular Sequen | 2009 |
Kinase domain mutations in cancer: implications for small molecule drug design strategies.
Topics: Amino Acid Sequence; Antineoplastic Agents; Drug Design; Enzyme Inhibitors; Humans; Molecular Sequen | 2009 |
Synthesis and pharmacological evaluations of novel 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as a new class of anti-cancer agents.
Topics: Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Drug Screening Assays, Antitumor; Huma | 2011 |
Synthesis and pharmacological evaluations of novel 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as a new class of anti-cancer agents.
Topics: Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Drug Screening Assays, Antitumor; Huma | 2011 |
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case.
Topics: 14-3-3 Proteins; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line; Drug Desig | 2011 |
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case.
Topics: 14-3-3 Proteins; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line; Drug Desig | 2011 |
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
Topics: Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Discoidin Domain Receptor 1; Drug Disc | 2013 |
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
Topics: Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Discoidin Domain Receptor 1; Drug Disc | 2013 |
Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; DNA; Humans; Intercal | 2015 |
Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; DNA; Humans; Intercal | 2015 |
Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzylide | 2020 |
Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzylide | 2020 |